NanoRepro AG Stock
Stocks
NN6
DE0006577109
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Xetra
11:35:43 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.600 EUR | -2.74% |
|
-7.25% | +6.31% |
| 07-29 | NanoRepro AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-01 | NanoRepro AG Announces Board Changes | CI |
| Market Cap | 20.18M 22.6M 18.64M 16.9M 31.61M 2.15B 32.13M 224M 88.82M 1.12B 84.81M 83.01M 3.54B | P/E 2026 * |
-12.3x | P/E 2027 * | -40x |
|---|---|---|---|---|---|
| Enterprise Value | 17.02M 19.06M 15.72M 14.25M 26.66M 1.81B 27.1M 189M 74.91M 948M 71.53M 70.01M 2.99B | EV / Sales 2026 * |
0.93x | EV / Sales 2027 * | 0.78x |
| Free-Float |
85.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| NN6 | Delayed | |
Tradegate
| NN6 | Real-time | |
Boerse Muenchen
| NN6 | Real-time | |
Deutsche Boerse AG
| NN6 | Delayed | |
Börse Stuttgart
| NN6 | Delayed |
| 05-29 | NanoRepro AG: Dr. Olaf Stiller, buy | EQ |
| 05-29 | NanoRepro AG: Lisa Jüngst, buy | EQ |
| 05-28 | NanoRepro AG: Lisa Jüngst, buy | EQ |
| 05-28 | NanoRepro AG: Dr. Olaf Stiller, buy | EQ |
| 05-28 | NanoRepro AG: Lisa Jüngst, buy | EQ |
| 1 day | -2.74% | ||
| 1 week | -7.25% | ||
| 1 month | -6.98% | ||
| 3 months | -23.81% | ||
| 6 months | +3.56% | ||
| Current year | +6.31% |
| 1 week | 1.58 | 1.78 | |
| 1 month | 1.55 | 1.8 | |
| Current year | 1.31 | 2.4 | |
| 1 year | 1.31 | 2.4 | |
| 3 years | 1.16 | 2.4 | |
| 5 years | 1.16 | 10.44 | |
| 10 years | 0.4 | 22.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lisa Jüngst
CEO | Chief Executive Officer | - | 2013-03-31 |
Stefan Pieh
DFI | Director of Finance/CFO | - | 2020-12-31 |
Maria Bugayev
SAM | Sales & Marketing | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Olaf Stiller
CHM | Chairman | 49 | 2012-12-31 |
Eva Maria Blank
BRD | Director/Board Member | - | 2023-06-14 |
| Director/Board Member | 49 | 2023-06-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/4/23 | Buy | Chief Executive Officer | 20,000 | 0.1550% | ||
| 5/17/23 | Buy | Chief Executive Officer | 5,000 | 0.0387% | ||
| 5/17/23 | Buy | Chief Executive Officer | 20,000 | 0.1550% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.74% | -7.25% | -3.90% | -30.43% | 22.6M | ||
| +1.16% | -1.13% | -18.25% | +9.38% | 179B | ||
| +0.02% | +4.24% | -19.55% | +15.88% | 118B | ||
| -1.22% | +0.70% | +1.86% | +32.59% | 117B | ||
| +2.29% | +17.36% | -42.18% | +8.22% | 93.26B | ||
| -2.21% | -2.91% | -0.51% | +75.12% | 63.16B | ||
| -1.06% | +1.75% | +13.48% | +74.12% | 55.68B | ||
| -0.75% | +3.73% | +7.04% | -23.26% | 54.18B | ||
| -1.13% | +0.00% | -12.56% | +30.09% | 44.15B | ||
| +0.17% | +5.85% | -5.20% | -11.43% | 33.95B | ||
| Average | -0.55% | +2.52% | -7.98% | +18.03% | 75.85B | |
| Weighted average by Cap. | -0.00% | +3.09% | -11.77% | +21.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.4M 20.6M 17M 15.4M 28.82M 1.96B 29.3M 205M 80.98M 1.02B 77.33M 75.68M 3.23B | 24.75M 27.72M 22.86M 20.72M 38.76M 2.63B 39.41M 275M 109M 1.38B 104M 102M 4.35B |
| Net income | -1.8M -2.02M -1.66M -1.51M -2.82M -191M -2.87M -20.01M -7.92M -100M -7.56M -7.4M -316M | -500K -560K -462K -419K -783K -53.15M -796K -5.56M -2.2M -27.85M -2.1M -2.06M -87.8M |
| Net Debt | -3.16M -3.54M -2.92M -2.65M -4.95M -336M -5.03M -35.13M -13.91M -176M -13.28M -13M -555M | -915K -1.02M -845K -766K -1.43M -97.27M -1.46M -10.17M -4.03M -50.96M -3.85M -3.76M -161M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | €1.600 | -2.74% | 12,600 |
| 26-10-22 | €1.645 | -3.80% | 2,306 |
| 26-10-21 | €1.710 | -3.93% | 1,472 |
| 26-10-20 | €1.780 | +2.01% | 1,853 |
| 26-10-19 | €1.745 | +1.16% | 150 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Annual profits - Rate of surprise
- Stock Market
- Stocks
- NN6 Stock
Select your edition
All financial news and data tailored to specific country editions

















